Life Sciences and Technology IPO and SPAC Overview Panel

LinkedIn Share Button Twitter Share Button Other Share Button Other Share Button

Presented on February 8, 2021

Findley Gillespie, Partner, Life Sciences Practice
Jeremy Kuhlmann, Partner, Life Sciences Practice
Amanda Rose, Corporate Partner, Fenwick

2020 was another active year in the life sciences and technology markets, despite the impacts of COVID-19. View our panel with Moss Adams Partners Jeremy Kuhlmann and Findley Gillespie and Fenwick Corporate Partner Amanda Rose, as we recap 2020, look at 2021, and discuss considerations for companies contemplating public exits via initial public offerings (IPOs) or special purpose acquisition companies (SPACs).

Related Topics

Contact Us with Questions

Assurance, tax, and consulting offered through Moss Adams LLP. ISO/IEC 27001 services offered through Moss Adams Certifications LLC. Investment advisory offered through Moss Adams Wealth Advisors LLC. Services from India provided by Moss Adams (India) LLP.